These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

654 related items for PubMed ID: 27032397

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Health Resource Utilization and Cost for Patients with Incontinent Overactive Bladder Treated with Anticholinergics.
    Yehoshua A, Chancellor M, Vasavada S, Malone DC, Armstrong EP, Joshi M, Campbell K, Pulicharam R.
    J Manag Care Spec Pharm; 2016 Apr; 22(4):406-13. PubMed ID: 27023694
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatments for overactive bladder: focus on pharmacotherapy.
    Geoffrion R, UROGYNAECOLOGY COMMITTEE.
    J Obstet Gynaecol Can; 2012 Nov; 34(11):1092-1101. PubMed ID: 23231848
    [Abstract] [Full Text] [Related]

  • 8. Impact of urinary incontinence on healthcare resource utilization, health-related quality of life and productivity in patients with overactive bladder.
    Tang DH, Colayco DC, Khalaf KM, Piercy J, Patel V, Globe D, Ginsberg D.
    BJU Int; 2014 Mar; 113(3):484-91. PubMed ID: 24528881
    [Abstract] [Full Text] [Related]

  • 9. Effect of anticholinergic use for the treatment of overactive bladder on cognitive function in postmenopausal women.
    Geller EJ, Crane AK, Wells EC, Robinson BL, Jannelli ML, Khandelwal CM, Connolly A, Parnell BA, Matthews CA, Dumond JB, Busby-Whitehead J.
    Clin Drug Investig; 2012 Oct 01; 32(10):697-705. PubMed ID: 22873491
    [Abstract] [Full Text] [Related]

  • 10. Assessment of treatment-seeking behavior and healthcare utilization in an international cohort of subjects with overactive bladder.
    Jimenez-Cidre M, Costa P, Ng-Mak D, Sahai A, Degboe A, Smith CP, Tsai K, Herschorn S.
    Curr Med Res Opin; 2014 Aug 01; 30(8):1557-64. PubMed ID: 24762033
    [Abstract] [Full Text] [Related]

  • 11. Long-term patterns of use and treatment failure with anticholinergic agents for overactive bladder.
    Chancellor MB, Migliaccio-Walle K, Bramley TJ, Chaudhari SL, Corbell C, Globe D.
    Clin Ther; 2013 Nov 01; 35(11):1744-51. PubMed ID: 24091072
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of anticholinergics in Korean children with overactive bladder: a multicenter retrospective study.
    Park SJ, Pai KS, Kim JM, Park K, Kim KS, Song SH, Park S, Kim SO, Ryu DS, Baek M, Lee SD, Lee JW, Im YJ, Han SW, Chung JM, Cho MH, Ha TS, Cho WY, Suh HJ, Korean Children's Continence and Enuresis Society.
    J Korean Med Sci; 2014 Nov 01; 29(11):1550-4. PubMed ID: 25408588
    [Abstract] [Full Text] [Related]

  • 15. One treatment with onabotulinumtoxinA relieves symptoms of overactive bladder in patients refractory to one or more oral medications.
    Farrelly E, Hamid R, Lorenzo-Gomez MF, Schulte-Baukloh H, Yu J, Patel A, Nelson M.
    Neurourol Urodyn; 2023 Aug 01; 42(6):1203-1213. PubMed ID: 37260130
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.